Loading provider…
Loading provider…
Internal Medicine Physician in Carnegie, PA
NPI: 1417911587Primary Practice Location
Preferred Primary Care Physicians, Inc.
2375 Greentree Rd, Carnegie, PA
Primary Employer
Preferred Primary Care Physicians, Inc.
ppcp.org
HQ Phone
Get M.D. Paul's Phone Numberphone_androidMobile
Get M.D. Paul's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardPW State Medical License
PA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 36415Insertion of needle into vein for collection of blood sample | 260 | 513 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 256 | 520 |
| 3 | G0439Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 231 | 231 |
| 4 | 80048Blood test, basic group of blood chemicals | 221 | 339 |
| 5 | G0444Annual depression screening, 15 minutes | 217 | 217 |
Authors: Hartley, Paul, Shentu, Yue, Betz-Schiff, Patricia, Golm, Gregory T, Sisk, Christine McCrary, Engel, Samuel S, Shankar, R Ravi
Journal: Drugs Aging
The Impact of Reactogenicity After the First Dose of Recombinant Zoster Vaccine on the Physical Functioning and Quality of Life of Older Adults: An Open-Label, Phase III Trial.
Authors: Kari Uusinarkaus, Charles Fogarty, Max Nevarez, David Butuk, Nicola Klein, Myron Levin
Publication Date: 2018-03-02
Lead Sponsor: GlaxoSmithKline
Intervention / Treatment: COMBINATION_PRODUCT: Placebo, COMBINATION_PRODUCT: rMenB+OMV NZ vaccine, BIOLOGICAL: Meningococcal Groups A, C, W and Y Conjugate Vaccine (MenACWY), COMBINATION_PRODUCT: MenABCWY-1, COMBINATION_PRODUCT: MenABCWY-2, COMBINATION_PRODUCT: MenABCWY-3
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo, DRUG: Tirzepatide
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Tirzepatide, DRUG: Antihyperglycemic medication